Symbol="FREQ"
AssetType="Common Stock"
Name="Frequency Therapeutics Inc"
Description="Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse the damage caused by a variety of degenerative diseases. The company is headquartered in Woburn, Massachusetts."
CIK="1703647"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="19 PRESIDENTIAL WAY, SUITE 203, WOBURN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="24260600"
EBITDA="-72045000"
PERatio="None"
PEGRatio="None"
BookValue="1.489"
DividendPerShare="0"
DividendYield="0"
EPS="-2.3"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.352"
ReturnOnEquityTTM="-0.937"
RevenueTTM="0"
GrossProfitTTM="-42015000"
DilutedEPSTTM="-2.3"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="7.5"
PriceToBookRatio="0.908"
EVToRevenue="0.0983"
EVToEBITDA="-0.235"
Beta="0.691"
num_52WeekHigh="5.59"
num_52WeekLow="0.326"
num_50DayMovingAverage="0.428"
num_200DayMovingAverage="1.441"
SharesOutstanding="36926300"
DividendDate="None"
ExDividendDate="None"
symbol="FREQ"
open="0.69"
high="0.74"
low="0.66"
price="0.72"
volume="916714.00"
latest_trading_day="2023-08-04"
previous_close="0.66"
change="0.07"
change_percent="10.3501%"
aroon_positive_momentum_days="16"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="1188000"
Change_recent_avg="0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="0.24"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_negative_thumbnail_id_2="1143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
